MedTrace Logo

VICIS - Vienna Cirrhosis Study

NCT03267615 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 10000

Last updated 2025-09-25

No results posted yet for this study

Summary

Patients with advanced chronic liver diseases treated at the Vienna General Hospital of the Medical University of Vienna will be offered to participate in this prospective observational trial - including an optional participation in a biobank.

Clinical parameters and laboratory parameters will be recorded for all patients and patients will undergo a regular follow-up schedule with clinical visits at the Vienna General Hospital.

This study is linked to a biobank with serum/plasma, ascitic fluid, urine, GI tract mucosal biopsies, liver biopsies and stool collected from the study participants.

Conditions

  • Liver Cirrhosis
  • Portal Hypertension
  • Ascites
  • Variceal Hemorrhage
  • Hepatic Encephalopathy

Sponsors & Collaborators

  • Medical University of Vienna

    lead OTHER

Principal Investigators

  • Thomas Reiberger, M.D. · Medical University of Vienna

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-02-01
Primary Completion
2026-12-31
Completion
2027-12-31

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03267615 on ClinicalTrials.gov